Latest Toxoplasma gondii Stories
About one-third of the human population is infected with a parasite called Toxoplasma gondii, but most of them don't know it.
Researchers at Washington University School of Medicine in St Louis have learned why changes in a single gene, ROP18, contribute substantially to dangerous forms of the parasite Toxoplasma gondii.
The protozoan parasite Toxoplasma gondii and the pathogenic bacterium Chlamydia trachomatis exemplify convergent evolution, the development of a similar biological trait in unrelated lineages.
Prenatal treatment of congenital toxoplasmosis with antibiotics might substantially reduce the proportion of infected fetuses that develop serious neurological sequelae (brain damage, epilepsy, deafness, blindness, or developmental problems) or die, and could be particularly effective in fetuses whose mothers acquired Toxoplasma gondii, the parasite that causes toxoplasmosis, during the first third of pregnancy.
The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, and even computer keyboards is pointing scientists toward a long-sought new treatment for a parasitic disease that affects almost two billion people.
Researchers at Washington University School of Medicine in St. Louis have identified a parasite protein that has all the makings of a microbial glass jaw: it's essential, it's vulnerable and humans have nothing like it, meaning scientists can take pharmacological swings at it with minimal fear of collateral damage.
Team liberates cellular hostages by silencing Toxoplasma gondii's back-seat driving.
An international team led by researchers from the University of Cordoba (UCO) has analyzed seroprevalence (antibodies to a disease) of Toxoplasma Gondii, the parasite that causes toxoplasmosis in many species, including humans.
In what's described as a genetic leap, U.S. researchers have discovered how to destroy a key DNA pathway in a widespread human parasite. Dartmouth Medical School scientists said their findings could help fast track vaccine and drug development to prevent or mitigate serious global diseases.
In a genetic leap that could help fast track vaccine and drug development to prevent or tame serious global diseases, DMS researchers have discovered how to destroy a key DNA pathway in a wily and widespread human parasite.